Americans are living in parallel AI universes. For much of the country, AI has come to mean ChatGPT, Google’s AI overviews, ...
Institutional participation remains broad, reflecting sustained allocation interest in semiconductor leadership themes NVIDIA ...
Novartis announced positive Phase III results from the RemIND trial showing that the oral BTK inhibitor remibrutinib achieved significantly higher complete response rates than placebo in three major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results